Department of Endocrinology, Hospital JM Ramos Mejía, Urquiza 609, Zip Code 1221, Buenos Aires, Argentina.
Department of Endocrinology, Hospital JM Ramos Mejía, Urquiza 609, Zip Code 1221, Buenos Aires, Argentina.
Endocrinol Diabetes Nutr (Engl Ed). 2021 Apr;68(4):227-235. doi: 10.1016/j.endien.2020.07.003.
21-hydroxylase deficiency (21-OHD) is the most common form of congenital adrenal hyperplasia (CAH). In adulthood, most studies are reported in females. By contrast, data on adult males are scarce.
To describe a series of adult males with classic 21-OHD and to assess the presence of adrenal masses and testicular adrenal rest tumors (TARTs).
Eight males (21-42 years) were included. We evaluated clinical presentation, 17-Hydroxyprogesterone (17-OHP), Testosterone (T), Δ4Androstenedione (Δ4A) ACTH, LH, FSH and plasma renin activitiy (PRA) levels at consultation. Molecular studies of the CYP21A2 gene, testicular ultrasound (US), semen analysis and adrenal computed tomography (CT) scan were performed. Treatment and compliance were assessed.
Basal 17-OHP levels were >20ng/ml in all patients. At consultation, median 17OH-P was 11.5 (2.3-81) ng/ml, FSH: 3 (0.3-4) mUI/ml, LH: 1.1 (0.1-6) mUI/ml, T: 4.3 (1.7-8) ng/ml, Δ4A: 5.7 (1.4-16) ng/ml, ACTH: 86.4 (76-334) pg/ml, PRA: 9.5 (1.3-23.6) ng/ml/h. Semen analysis was performed in 5/8 patients, showing azoospermia in two. Molecular genetic analysis was performed in 4/8 patients. TARTs were found in 5/6, being bilateral in four. Adrenal masses were found in 4/6. In the 7 patients diagnosed in childhood, their follow-up was referred to as irregular, both in their attendance at consultations and in compliance with the indicated treatment.
To our knowledge, this is the first series on adult males with classic 21-OHD which concomitantly assesses clinical presentation, molecular biology, adrenal and testicular imaging studies, semen analysis and compliance to treatment. A high prevalence of adrenal masses and TARTs was observed, possibly associated with poor treatment compliance leading to elevated ACTH and increased proliferation. Our findings on TARTs agree with reports in international publications of CAH in males, with adrenal imaging being added in our group. Although we are aware that further studies with a larger sample size and more data are needed, we consider that our findings contribute to the clinical management of classical 21-OHD in the male population.
21-羟化酶缺乏症(21-OHD)是最常见的先天性肾上腺皮质增生症(CAH)类型。在成年期,大多数研究报告都是针对女性的。相比之下,关于成年男性的数据则较为稀缺。
描述一系列患有典型 21-OHD 的成年男性,并评估其是否存在肾上腺肿块和睾丸肾上腺残瘤(TART)。
共纳入 8 名男性(21-42 岁)。我们评估了他们的临床表现、17-羟孕酮(17-OHP)、睾酮(T)、Δ4 雄烯二酮(Δ4A)、促肾上腺皮质激素(ACTH)、黄体生成素(LH)、卵泡刺激素(FSH)和血浆肾素活性(PRA)水平。对 CYP21A2 基因进行了分子研究,还进行了睾丸超声(US)、精液分析和肾上腺计算机断层扫描(CT)检查。评估了治疗和依从性。
所有患者的基础 17-OHP 水平均>20ng/ml。就诊时,中位数 17OH-P 为 11.5(2.3-81)ng/ml,FSH:3(0.3-4)mIU/ml,LH:1.1(0.1-6)mIU/ml,T:4.3(1.7-8)ng/ml,Δ4A:5.7(1.4-16)ng/ml,ACTH:86.4(76-334)pg/ml,PRA:9.5(1.3-23.6)ng/ml/h。对 5/8 名患者进行了精液分析,其中 2 名患者无精子症。对 4/8 名患者进行了分子遗传学分析。在 6 名 TART 患者中发现了 5 名,其中 4 名为双侧。在 6 名患者中发现了 4 名肾上腺肿块。在 7 名在儿童期确诊的患者中,他们的随访被认为是不规律的,无论是在就诊还是在遵守规定的治疗方面。
据我们所知,这是第一个同时评估经典 21-OHD 成年男性临床表现、分子生物学、肾上腺和睾丸影像学研究、精液分析和治疗依从性的系列研究。我们观察到高比例的肾上腺肿块和 TART,这可能与治疗依从性差导致 ACTH 升高和增殖增加有关。我们关于 TART 的发现与国际出版物中关于男性 CAH 的报告一致,我们的研究还增加了肾上腺影像学检查。尽管我们知道需要进一步开展更大规模和更多数据的研究,但我们认为我们的发现有助于管理男性人群中的经典 21-OHD。